A Study of Glucosylceramide Synthase and Glycolytic Pathway Enzymes in Patients with Hypereosinophilia
<p>Glucosylceramide synthase is the rate limiting enzyme in ceramide glycosylation and shifts the balance between ceramide and glycosphingolipids towards proliferation and survival of cancer cells. Increased glucose availability and glycolytic metabolism is preferentially used by cancer cells...
Saved in:
Main Authors: | Lisa Redmond (Author), Paul Kennedy (Author), Colm Buckley (Author), Philip T Murphy (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2017-03-31.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantification of glucosylceramide in plasma of Gaucher disease patients
by: Maria Viviane Gomes Muller, et al.
Published: (2010) -
Glycolytic enzyme inhibitory and antiglycation potential of rutin
by: Shagun Dubey, et al.
Published: (2017) -
Successful use of antihistamines in severe hypereosinophilia
by: Stefano Vallero, et al.
Published: (2012) -
Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
by: Shiyu Zhang, et al.
Published: (2023) -
Lymphoid aggregates in bone marrow biopsies in patients with hypereosinophilia
by: Sharma Seema, et al.
Published: (2008)